Navigation Links
Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland
Date:5/23/2013

WASHINGTON, May 23, 2013 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced that the company has been named the 2013 Life Science Firm of the Year by the Tech Council of Maryland (TCM).  Vanda was honored at the TCM's 25th Annual Tech Awards Celebration held in Bethesda, Maryland.  The Tech Awards Celebration recognizes the leaders and innovators in the technology and life science communities in Maryland and the surrounding regions.

"We are deeply honored to receive this recognition from the Tech Council of Maryland," said Mihael H. Polymeropoulos , M.D., President and CEO of Vanda.  "We are privileged to work in a region that is supportive of our efforts to develop new treatments designed to improve the lives of others."

In selecting Vanda for this award, the TCM recognized Vanda's commitment to address patient needs and the company's work to develop tasimelteon, a circadian regulator, for the treatment of Non-24-Hour Disorder (Non-24).  Vanda recently announced positive results in the SET and RESET Phase III efficacy studies for Non-24.  Non-24 is a serious, rare circadian rhythm disorder that affects a majority of totally blind individuals.  Currently no treatment for Non-24 has been approved by the U.S. Food and Drug Administration (FDA).  Vanda is targeting a New Drug Application submission with the FDA for tasimelteon in mid-2013.

About The Tech Council of Maryland  
The Tech Council of Maryland (TCM) is the largest technology trade group serving the advanced technology and biotechnology communities of Maryland.  TCM's mission is to
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Vanda Pharmaceuticals to Announce First Quarter 2013 Financial Results on May 9, 2013
2. Vanda Pharmaceuticals to Present at the BioCentury Future Leaders in the Biotech Industry Conference
3. Vanda Reports Successful Completion Of Pre-NDA Meeting With FDA On Tasimelteon For The Treatment Of Non-24-Hour Disorder In The Totally Blind
4. Vanda Pharmaceuticals to Present at the Cowen and Company 33rd Annual Health Care Conference
5. Vanda Pharmaceuticals Reports Fourth Quarter 2012 and Full Year 2012 Results
6. Vanda Announces Phase IIb/III Clinical Study In Major Depressive Disorder Did Not Meet The Primary Endpoint
7. Vanda Announces Positive Results in the Second Phase III Study (RESET) of Tasimelteon for the Treatment of Non-24-Hour Disorder
8. Vanda Pharmaceuticals to Announce Fourth Quarter 2012 Financial Results on February 12, 2013
9. Vanda Pharmaceuticals Reports Third Quarter 2012 Results
10. Vanda Pharmaceuticals to Participate in Two September Healthcare Investor Conferences
11. Vanda Pharmaceuticals to Announce Second Quarter 2012 Financial Results on August 2, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... Mike Rowe , spokesperson and reality television personality, will ... 2015 ThoughtSpot conference and tradeshow, which runs from ... Nev. Best known for his ... Channel,s, "Dirty Jobs," Mr. Rowe spent a decade traveling across ... whose hard work, sacrifice and value aren,t always recognized. Prior ...
(Date:7/28/2015)... VirtualScopics, Inc. (NASDAQ: VSCP ), a ... that it will report its second quarter 2015 financial ... Tuesday, August 11, 2015.  Eric T. Converse , ... , chief financial officer, will host a conference call ... provide a business update at 4:30 p.m. ET that ...
(Date:7/28/2015)... Calif. , July 28, 2015  Xencor, Inc. ... engineered monoclonal antibodies for the treatment of autoimmune diseases, ... will release second quarter 2015 financial results after the ... will host a webcast and conference call the same ... discuss the financial results and provide a corporate update. ...
Breaking Medicine Technology:Mike Rowe to Address Community Pharmacists at ThoughtSpot 2015 2VirtualScopics, Inc. Schedules Second Quarter 2015 Financial Results Press Release, Conference Call And Webcast 2VirtualScopics, Inc. Schedules Second Quarter 2015 Financial Results Press Release, Conference Call And Webcast 3Xencor to Host Second Quarter 2015 Financial Results Webcast and Conference Call on August 4, 2015 2
... Kaiser Foundation Health Plan, Inc., Kaiser Foundation Hospitals (KFHP/H), and ... $10.5 billion for the quarter ended September 30, 2009, compared ... Operating income in the third quarter was $336 million, compared ... Net non-operating income was $233 million in the third quarter, ...
... Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD ) ... a final approval from the US Food and ... Drug Application (ANDA) for generic Acular® ophthalmic solution ... strength of ketorolac is therapeutically equivalent to Acular® ...
Cached Medicine Technology:Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 2Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 3Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 4Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Ophthalmic Solution 2
(Date:7/28/2015)... Viejo, CA (PRWEB) , ... July 28, 2015 , ... ... Final Cut Pro X . With ProFont: Cursive users can generate a hand ... is fully customizable leaving endless stylization. Users can select from either the upper and ...
(Date:7/28/2015)... , ... July 28, 2015 , ... A skin cancer ... a national 2015 Power of A award for “helping to make the world a ... A Gold Award winner by the American Society of Association Executives. Power of A ...
(Date:7/28/2015)... ... July 28, 2015 , ... ... announces Skimmer Helper, a household invention that cleans pools efficiently - minus the ... says Scott Cooper, CEO and Creative Director of World Patent Marketing. "It is ...
(Date:7/28/2015)... , ... July 28, 2015 , ... Mindful Her, a ... ages to take their healthy and mindful living practices to the next level, announced ... author of Living with Intent as keynote. Global Girls, an Orange County based ...
(Date:7/28/2015)... ... July 28, 2015 , ... ... examines outcomes for inmates who continued methadone maintenance treatment (MMT) during incarceration versus ... likely to relapse to opiate use (1) and more likely to require hospitalization ...
Breaking Medicine News(10 mins):Health News:Announcing ProFont Cursive from FCPX Effects developer Pixel Film Studios 2Health News:ASDS Skin Cancer Program Honored 2Health News:ASDS Skin Cancer Program Honored 3Health News:10 Fascinating Things You Never Knew About Swimming Pools Is Introduced by World Patent Marketing and Skimmer Helper 2Health News:10 Fascinating Things You Never Knew About Swimming Pools Is Introduced by World Patent Marketing and Skimmer Helper 3Health News:10 Fascinating Things You Never Knew About Swimming Pools Is Introduced by World Patent Marketing and Skimmer Helper 4Health News:10 Fascinating Things You Never Knew About Swimming Pools Is Introduced by World Patent Marketing and Skimmer Helper 5Health News:Women’s Healthy Living Event Mindful Her Set for October 24, 2015 in Orange County 2Health News:Women’s Healthy Living Event Mindful Her Set for October 24, 2015 in Orange County 3Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 2Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 3Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 4
... up and take notice in health care apart from AIDS or ... enough to bolster people to sit up and listen. But should ... disease? Or should we use our gray cells and analyse the ... is written about and said about the dreaded disease? Especially so ...
... couples who are HIV sero discordant but who would like to ... the wife is negative and they are planning to have a ... 500 risk of transmitting the virus to the female partner and ... in which infected sperm are washed free of virus before insemination ...
... – the deadly Ebola virus in its latest outbreak has ... Ministry officials in Kampala. More shocking is the fact ... nurses. But what shocked the nation was the death ... the fight against Ebola in Gulu. There is no ...
... publish its findings on the human genome project ... the mapping of the genes will enable one to have ... the eye or even skin. It will also help say ... to screen babies in the womb for diseases, and device ...
... published in the December issue of the Journal ... in peripheral blood mononuclear cells (PBMCs) from individuals ... infected patients treated with antifilarial agents. According ... the National Institute of Allergy and Infectious Diseases ...
... clue if the heart attack patients should get an immediate ... their hearts. , ,Cleveland Clinic cardiologist, Dr. Deepak Bhatt ... and found that patients whose white blood cell count is ... much higher risk of death after a heart attack than ...
Cached Medicine News:Health News:The Cancer Rumour mill working over time 2Health News:Sperm washing helps couples – Breakthrough in focu 2
McPherson curved tying forceps made of titanium has curved shafts with 8 mm tying platforms, width of shafts 0,25 mm, TCI platforms, flat handle, width 6 mm, overall length 85 mm....
Straight tying spring forceps made of titanium, delicate smooth jaws, length 10 mm, TCI jaws with round handle, diam. 8 mm and overall length 115 mm....
McPherson straight tying forceps made of titanium, straight shafts with 4 mm tying platforms, width of shafts 0,25 mm, TCI platforms, flat handle, width 6 mm, overall length 87 mm....
Bonn long model micro tying forceps....
Medicine Products: